"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"

NCT07684326 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Ascites Hepatic

Interventions

DRUG: Dapagliflozin

Sponsor

Beni-Suef University